Trial intelligence / Profile preview

Local 5-Fluorouracil for Chalazia

NCT02025023Phase 3Recruiting

Sponsor
University of Washington
Start
Dec 2013
Primary completion
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluorouracil in chalazion, sponsored by University of Washington. Started Dec 2013; status: recruiting.

02

Drugs

fluorouracil
03

Conditions

chalazion

Beyond the preview

Go deeper on NCT02025023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02025023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call